Penumbra, Inc. (PEN)

NYSE: PEN · Real-Time Price · USD
288.73
-0.52 (-0.18%)
May 8, 2025, 4:00 PM - Market closed
-0.18%
Market Cap 11.18B
Revenue (ttm) 1.24B
Net Income (ttm) 42.23M
Shares Out 38.73M
EPS (ttm) 1.08
PE Ratio 267.83
Forward PE 72.03
Dividend n/a
Ex-Dividend Date n/a
Volume 300,562
Open 290.02
Previous Close 289.25
Day's Range 288.32 - 294.28
52-Week Range 148.00 - 310.00
Beta 0.53
Analysts Strong Buy
Price Target 299.73 (+3.81%)
Earnings Date Apr 23, 2025

About PEN

Penumbra, Inc., together with its subsidiaries, designs, develops, manufactures, and markets medical devices in the United States and internationally. The company offers peripheral thrombectomy products, including the Indigo System for power aspiration of thrombus in the body; Lightning Flash, a mechanical thrombectomy system; Lightning Bolt 7, an arterial thrombectomy system; and CAT RX. It also provides access products, including guide catheters and the Penumbra distal delivery catheters under the Neuron, Neuron MAX, BENCHMARK, BMX, DDC, MIDW... [Read more]

Industry Medical Devices
Sector Healthcare
IPO Date Sep 18, 2015
Employees 4,500
Stock Exchange NYSE
Ticker Symbol PEN
Full Company Profile

Financial Performance

In 2024, Penumbra's revenue was $1.19 billion, an increase of 12.86% compared to the previous year's $1.06 billion. Earnings were $14.01 million, a decrease of -84.59%.

Financial Statements

Analyst Forecast

According to 16 analysts, the average rating for PEN stock is "Strong Buy." The 12-month stock price forecast is $299.73, which is an increase of 3.81% from the latest price.

Price Target
$299.73
(3.81% upside)
Analyst Consensus: Strong Buy
Stock Forecasts

News

Penumbra, Inc. to Present at the BofA Securities 2025 Health Care Conference

ALAMEDA, Calif. , April 29, 2025 /PRNewswire/ -- Penumbra, Inc. (NYSE: PEN) today announced that its management team is scheduled to present at the BofA Securities 2025 Health Care Conference on Tuesd...

9 days ago - PRNewsWire

Baron Health Care Fund Q1 2025 Top Net Purchases And Sales

Initiated positions in Waters Corporation, Penumbra, McKesson, Masimo, and added to UnitedHealth Group due to strong market positions and growth potential. Waters Corporation's growth driven by biopha...

9 days ago - Seeking Alpha

Penumbra Among Well-Insulated Companies From Ongoing Tariff Dynamics, Says Analyst

Penumbra Inc PEN stock is trading higher after the company reported better-than-expected first-quarter 2025 earnings and reaffirmed the 2025 forecast.

14 days ago - Benzinga

Penumbra, Inc. (PEN) Q1 2025 Earnings Call Transcript

Penumbra, Inc. (NYSE:PEN) Q1 2025 Earnings Conference Call April 23, 2025 4:30 PM ET Company Participants Cecilia Furlong - Business Development & IR Adam Elsesser - Chairman & CEO Maggie Yuen - CFO ...

15 days ago - Seeking Alpha

Penumbra, Inc. Reports First Quarter 2025 Financial Results

ALAMEDA, Calif. , April 23, 2025 /PRNewswire/ -- Penumbra, Inc. (NYSE: PEN), the world's leading thrombectomy company, today reported financial results for the first quarter ended March 31, 2025.

15 days ago - PRNewsWire

Penumbra, Inc. Schedules First Quarter 2025 Earnings Release and Conference Call for April 23, 2025

ALAMEDA, Calif. , April 3, 2025 /PRNewswire/ -- Penumbra, Inc. (NYSE: PEN) today announced that it will host a conference call to discuss financial results for the first quarter 2025 after market clos...

5 weeks ago - PRNewsWire

Seven New Data Sets Demonstrate Penumbra's Computer Assisted Vacuum Thrombectomy (CAVT) Technology Is Safe, Fast and Effective, Improves Patient Outcomes, and Delivers Healthcare Resource Benefits

ALAMEDA, Calif. , April 2, 2025 /PRNewswire/ -- Penumbra, Inc. (NYSE: PEN), the world's leading thrombectomy company, announced seven significant computer assisted vacuum thrombectomy (CAVT™) data pre...

5 weeks ago - PRNewsWire

Penumbra, Inc. Announces Don Kassing will Retire from Board of Directors

ALAMEDA, Calif. , Feb. 21, 2025 /PRNewswire/ -- Penumbra, Inc. (NYSE: PEN), the world's leading thrombectomy company, announced today that after 17 years of distinguished service, Don Kassing has noti...

2 months ago - PRNewsWire

Stroke Device Maker Penumbra Stock Surges On Earnings Beat, Analysts Boost Price Forecasts After Upbeat 2025 Outlook

Penumbra Inc PEN is trading higher after the company reported better-than-expected fourth-quarter earnings.

2 months ago - Benzinga

Penumbra, Inc. (PEN) Q4 2024 Earnings Call Transcript

Penumbra, Inc. (NYSE:PEN) Q4 2024 Earnings Conference Call February 18, 2025 4:30 PM ET Company Participants Cecilia Furlong - Director of Business Development and Investor Relations Adam Elsesser - ...

2 months ago - Seeking Alpha

Penumbra, Inc. Reports Fourth Quarter and Full Year 2024 Financial Results

ALAMEDA, Calif. , Feb. 18, 2025 /PRNewswire/ -- Penumbra, Inc. (NYSE: PEN), the world's leading thrombectomy company, today reported financial results for the fourth quarter and full year ended Decemb...

2 months ago - PRNewsWire

Penumbra, Inc. Schedules Fourth Quarter and Full Year 2024 Earnings Release and Conference Call for February 18, 2025

ALAMEDA, Calif. , Jan. 21, 2025 /PRNewswire/ -- Penumbra, Inc. (NYSE: PEN) today announced that it will host a conference call to discuss financial results for the fourth quarter and full year 2024 af...

3 months ago - PRNewsWire

Penumbra, Inc. to Present at the 43rd Annual J.P. Morgan Healthcare Conference

ALAMEDA, Calif. , Dec. 30, 2024 /PRNewswire/ -- Penumbra, Inc. (NYSE: PEN) today announced that its management team is scheduled to present at the 43rd Annual J.P.

4 months ago - PRNewsWire

Penumbra Is Poised For Growth As Blood Clot Awareness Rises: Analyst

Shares of Penumbra Inc PEN recovered slightly in early trading on Tuesday, after a week of correction.

5 months ago - Benzinga

Penumbra, Inc. to Present at the Piper Sandler 36th Annual Healthcare Conference

ALAMEDA, Calif. , Nov. 20, 2024 /PRNewswire/ -- Penumbra, Inc. (NYSE: PEN) today announced that its management team is scheduled to present at the Piper Sandler 36th Annual Healthcare Conference on We...

6 months ago - PRNewsWire

New Late Breaking Data Show Patients Treated with Penumbra's Computer Assisted Vacuum Thrombectomy Technology for Pulmonary Embolism Experience Shorter Hospital Stays and Fewer Complications Compared to Other Treatment Options

Data presented for the first time this week at Vascular Interventional Advances (VIVA) 2024 Conference Findings reinforce the clinical, health economic and cost benefits of computer assisted vacuum th...

6 months ago - PRNewsWire

Penumbra, Inc. (PEN) Q3 2024 Earnings Call Transcript

Penumbra, Inc. (NYSE:PEN) Q3 2024 Earnings Conference Call October 30, 2024 4:30 PM ET Company Participants Cecilia Furlong - Director of Business Development and Investor Relations Adam Elsesser - C...

6 months ago - Seeking Alpha

Penumbra, Inc. Reports Third Quarter 2024 Financial Results

ALAMEDA, Calif. , Oct. 30, 2024 /PRNewswire/ -- Penumbra, Inc. (NYSE: PEN), the world's leading thrombectomy company, today reported financial results for the third quarter ended September 30, 2024.

6 months ago - PRNewsWire

Penumbra, Inc. Announces Completion of THUNDER IDE Study Enrollment for Acute Ischemic Stroke

ALAMEDA, Calif. , Oct. 14, 2024 /PRNewswire/ -- Penumbra, Inc. (NYSE: PEN), the world's leading thrombectomy company, announced the completion of enrollment in its THUNDER clinical study for patients ...

7 months ago - PRNewsWire

Penumbra, Inc. Schedules Third Quarter 2024 Earnings Release and Conference Call for October 30, 2024

ALAMEDA, Calif. , Oct. 2, 2024 /PRNewswire/ -- Penumbra, Inc. (NYSE: PEN) today announced that it will host a conference call to discuss financial results for the third quarter 2024 after market close...

7 months ago - PRNewsWire

Penumbra Receives CE Mark for Computer Assisted Vacuum Thrombectomy Technologies - Lightning Flash™ 2.0 and Lightning Bolt™ 7 - in Europe

Latest computer assisted vacuum thrombectomy (CAVT) technologies combine superior catheter design with the latest dual clot detection computer algorithms designed to restore blood flow quickly Lightni...

8 months ago - PRNewsWire

Penumbra, Inc. to Present at the Baird Global Healthcare Conference

ALAMEDA, Calif. , Aug. 27, 2024 /PRNewswire/ -- Penumbra, Inc. (NYSE: PEN) today announced that its management team is scheduled to present at the Baird Global Healthcare Conference on Tuesday, Septem...

9 months ago - PRNewsWire

Penumbra, Inc. to Present at the Wells Fargo Healthcare Conference

ALAMEDA, Calif. , Aug. 21, 2024 /PRNewswire/ -- Penumbra, Inc. (NYSE: PEN) today announced that its management team is scheduled to present at the Wells Fargo Healthcare Conference on Wednesday, Septe...

9 months ago - PRNewsWire

Penumbra: Growth In Its Thrombectomy Portfolio Should Lead To Strong Earnings

Penumbra is continuing to take share with its new CAVT devices against its closest competition in the VTE space. PEN reduced guidance after Q2 earnings, but the market took it in stride, with difficul...

9 months ago - Seeking Alpha

Penumbra, Inc. Announces $200 Million Share Repurchase Authorization

To Include $100 Million Accelerated Share Repurchase ALAMEDA, Calif. , Aug. 13, 2024 /PRNewswire/ -- Penumbra, Inc. (NYSE: PEN), the world's leading thrombectomy company, today announced that its Boar...

9 months ago - PRNewsWire